Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
FAA warns of staffing issues and flight disruptions due to government shutdown, as essential workers go unpaid and lawmakers remain deadlocked.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
FAA warns of staffing issues and flight disruptions due to government shutdown, as essential workers go unpaid and lawmakers remain deadlocked.